We are live on
!
Find out more
QM
QVIDTVM Management Portfolio holdings
AUM
$81.4M
1-Year Est. Return
2.94%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
-2.94%
3 Year Est. Return
-15.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$92.9M
AUM Growth
-$6.93M
(-6.9%)
Cap. Flow
+$31.5M
Cap. Flow
% of AUM
33.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
5
Reduced
3
Closed
–
Top Buys
| 1 |
Rentokil
RTO
|
+$36.1M |
| 2 |
Dentsply Sirona
XRAY
|
+$454K |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$109K |
| 4 |
BRC Inc
BRCC
|
+$62.4K |
| 5 |
Coty
COTY
|
+$26.7K |
Top Sells
| 1 |
Zegna
ZGN
|
+$3.74M |
| 2 |
Solventum
SOLV
|
+$1.22M |
| 3 |
Wabtec
WAB
|
+$296K |
Sector Composition
| 1 | Healthcare | 83.95% |
| 2 | Consumer Staples | 12.61% |
| 3 | Industrials | 2.25% |
| 4 | Consumer Discretionary | 1.18% |
Similar funds
WP
MC
SPW
RTC
MWVC
FPAM
AGFVA
FRIHG
QVIDTVM Management's Q3 2025 Portfolio in Review
As of Q3 2025, QVIDTVM Management held 8 positions worth $92.9M, down 6.9% from $99.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
QVIDTVM Management deployed $31.5M of net new capital in Q3 2025, adding to 5 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 77% a quarter earlier, followed by Consumer Staples and Industrials.
On the sell side, the largest reduction was Zegna, an estimated $3.74M trimmed.
- QVIDTVM Management added most to Rentokil in Q3 2025, an estimated $36.1M increase.
- QVIDTVM Management's biggest Q3 2025 reduction was Zegna, cutting an estimated $3.74M.
- QVIDTVM Management's ten largest holdings make up 100% of its $92.9M portfolio in Q3 2025.
- QVIDTVM Management opened 0 new positions and closed 0 in Q3 2025.
- QVIDTVM Management's portfolio value fell 6.9% quarter-over-quarter to $92.9M.
Based on QVIDTVM Management's 13F filing for Q3 2025, filed 6 Nov 2025.